Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

6.47
Delayed Data
As of May 24
 +0.06 / +0.94%
Today’s Change
4.15
Today|||52-Week Range
10.28
-19.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues1.3M1.9M2.5M2.1M
 
 
 
 
 
Cost of Goods Sold1.8M994.9K1.4M2.4M
 
 
 
 
 
Depreciation And Amortization117.6K117.9K117.2K118.4K
 
 
 
 
 
 
Operating ExpensesGross Income-573.3K739.6K1.0M-423.0K
 
 
 
 
 
General Expenses2.9M5.4M5.1M3.7M
 
 
 
 
 
Research And Development1.5M2.1M2.0M2.0M
 
 
 
 
 
Total Operating Expenses4.8M6.5M6.6M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-4.7M-4.1M-4.2M
 
 
 
 
 
Extraordinary Charge-719.1K0.000.000.00
 
 
Interest Expense On Debt453.4K449.3K463.9K467.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-5.1M-4.6M-4.6M
 
 
 
 
 
Net Income-4.7M-5.1M-4.6M-4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.7M10.7M10.7M10.7M
 
 
 
 
 
Shares To Calculate EPS Diluted10.7M10.7M10.7M10.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.44-$0.48-$0.43-$0.43
 
 
 
 
 
EPS Diluted-$0.44-$0.48-$0.43-$0.43